The COVID-19 pandemic has struck the global population with unparalleled speed and ferocity. Researchers around the world are scrambling to learn about the biology, pathology, and genetics of SARS-CoV-2—the novel coronavirus responsible for COVID-19—while clinicians are seeking treatments, old and new, that might slow its infectivity and deadliness. In this webinar, we will explore what scientists are learning by using flow cytometry to study patients with COVID-19 in order to elucidate risk and disease severity. These experts are global leaders in cytometry and infectious disease, working on the frontlines of the COVID-19 outbreaks. They will provide concrete examples of how flow cytometry has been harnessed to provide key laboratory evidence that can be used in the fight against SARS-CoV-2 and COVID-19. Viewers will have the opportunity to put their questions to the expert panel during the live broadcast.
During the webinar, attendees will:
- Hear an overview of published literature related to the use of flow cytometry and immunophenotyping of the major lymphocyte subsets in relation to COVID-19 clinical research, particularly in China
- Learn about specific, ongoing clinical research in SARS-CoV-2 hotspots and the application of flow cytometry to identify biomarkers for COVID-19 severity
- Join a discussion on the implications of these findings as they relate to the international guidance for COVID-19 disease treatment and prevention in persons living with HIV.
This webinar will last for approximately 60 minutes.